Mutational Genomics for Cancer Pathway Discovery

We propose mutational genomics as an approach for identifying putative cancer pathways. This approach relies on expression profiling tumors that are induced by retroviral insertional mutagenesis. Akin to genetical genomics, this provides the opportunity to search for associations between tumor-initiating events (the viral insertion sites) and the consequent transcription changes, thus revealing putative regulatory interactions. An important advantage is that in mutational genomics the selective pressure exerted by the tumor growth is exploited to yield a relatively small number of loci that are likely to be causal for tumor formation. This is unlike genetical genomics which relies on the natural occurring genetic variation between samples to reveal the effects of a locus on gene expression. We performed mutational genomics using a set of 97 lymphoma from mice presenting with splenomegaly. This identified several known as well as novel interactions, including many known targets of Notch1 and Gfi1. In addition to direct one-to-one associations, many multilocus networks of association were found. This is indicative of the fact that a cell has many parallel possibilities in which it can reach a state of uncontrolled proliferation. One of the identified networks suggests that Zmiz1 functions upstream of Notch1. Taken together, our results illustrate the potential of mutational genomics as a powerful approach to dissect the regulatory pathways of cancer.

[1]  Luc Girard,et al.  Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. , 2007, Cancer research.

[2]  Andrea Califano,et al.  ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes , 2007, Proceedings of the National Academy of Sciences.

[3]  M. Ffrench,et al.  BTG1, a member of a new family of antiproliferative genes. , 1992, The EMBO journal.

[4]  Shili Lin,et al.  Rank aggregation methods , 2010 .

[5]  Johann de Jong,et al.  Computational identification of insertional mutagenesis targets for cancer gene discovery , 2011, Nucleic acids research.

[6]  David J. Adams,et al.  Cancer gene discovery in mouse and man , 2009, Biochimica et biophysica acta.

[7]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[8]  M. Katoh,et al.  Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer. , 2007, International journal of oncology.

[9]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[10]  H. Koeffler,et al.  Restoration of C/EBPα Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation* , 2003, Journal of Biological Chemistry.

[11]  Steven J. M. Jones,et al.  Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.

[12]  Rainer Breitling,et al.  Expression Quantitative Trait Loci Are Highly Sensitive to Cellular Differentiation State , 2009, PLoS genetics.

[13]  Stephen J. Elledge,et al.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest , 1994, Cell.

[14]  Anton Berns,et al.  Retroviral insertional mutagenesis: tagging cancer pathways. , 2003, Advances in cancer research.

[15]  Martin Schuler,et al.  Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.

[16]  Jaap Kool,et al.  High-throughput insertional mutagenesis screens in mice to identify oncogenic networks , 2009, Nature Reviews Cancer.

[17]  Marcel J. T. Reinders,et al.  Inferring combinatorial association logic networks in multimodal genome-wide screens , 2010, Bioinform..

[18]  Zhijun Duan,et al.  Targets of the transcriptional repressor oncoprotein Gfi-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Margit Burmeister,et al.  Genetical genomics: combining genetics with gene expression analysis. , 2005, Human molecular genetics.

[20]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[21]  E. Feinstein,et al.  Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53 , 1998, Oncogene.

[22]  Jeroen de Ridder,et al.  Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypes. , 2010, Cancer research.

[23]  Christian Gilissen,et al.  BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. , 2010, Blood.

[24]  T. Salmi,et al.  L-myc and N-myc in hematopoietic malignancies. , 1993, Leukemia & lymphoma.

[25]  A. Berns,et al.  Retroviral insertional mutagenesis: past, present and future , 2005, Oncogene.

[26]  J. Nap,et al.  Genetical genomics : the added value from segregation , 2001 .

[27]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Hubbard,et al.  Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks , 2008, Cell.

[29]  Andrew I Su,et al.  Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics' , 2005, Nature Genetics.

[30]  A. Berns,et al.  Retroviral insertional mutagenesis as a strategy to identify cancer genes. , 1996, Biochimica et biophysica acta.

[31]  D. Dudley,et al.  Hes1 Potentiates T Cell Lymphomagenesis by Up-Regulating a Subset of Notch Target Genes , 2009, PloS one.

[32]  Bob Löwenberg,et al.  Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia. , 2006, Cancer research.

[33]  Alice Gerrits,et al.  Combining transcriptional profiling and genetic linkage analysis to uncover gene networks operating in hematopoietic stem cells and their progeny , 2008, Immunogenetics.

[34]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .